About Korsana Biosciences, Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Waltham, MA
- Company type
- Privately Held
- Company profile name
- Korsana Biosciences
Korsana Biosciences is a private biopharmaceutical company advancing a pipeline of potential best-in-class therapies for neurodegenerative diseases. In partnership with Paragon Therapeutics, we have developed Therapeutic Targeting (THETA™), a novel blood-brain barrier-penetrant shuttle platform designed to enable dramatically higher drug concentration inside the brain and overcome the limitations of earlier shuttle technologies. Our lead program is KRSA-028, an investigational, shuttled antibody targeting amyloid beta designed to be a best-in-class treatment for Alzheimer’s disease. Our mission is to advance precision-engineered therapies, designed to address some of the biggest unmet needs in medicine. For more information, please visit www.korsana.com
Company locations
Waltham, MA, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Biopharma
- Biotechnology
- Medical
- Neuroscience
- Pharmaceutical
- Therapeutics
On LinkedIn
- Followers
- 3,795
- People linked to this company
- 26
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
175,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.